Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


March 27, 2015 7:10 PM ET

Healthcare Providers and Services

Company Overview of Ekso Bionics Holdings, Inc.

Company Overview

Ekso Bionics Holdings, Inc. designs, develops, and commercializes wearable robots or exoskeletons for use in the medical, military, industrial, and consumer markets in North America, Europe, the Middle East, and Asia. The company primarily offers Ekso GT, a bionic suit that provides individuals with spinal cord injuries, stroke, and other lower-extremity paralysis or weakness the ability to stand and walk over ground with a reciprocal gait using a cane, crutches, or a walker under the supervision of a physical therapist. Its Ekso device is used principally in a clinic or rehabilitation setting. The company was founded in 2005 and is headquartered in Richmond, California.

1414 Harbour Way South

Suite 1201

Richmond, CA 94804

United States

Founded in 2005

67 Employees

Phone:

203-723-3576

Fax:

510-927-2647

Key Executives for Ekso Bionics Holdings, Inc.

Co-Founder, Chief Executive Officer and Director
Age: 46
Total Annual Compensation: $401.1K
President and Chief Commercial Officer
Age: 42
Total Annual Compensation: $201.7K
Co-Founder, Chief Technology Officer and President of Ekso Labs Division
Age: 37
Total Annual Compensation: $323.0K
Chief Financial Officer
Age: 52
Total Annual Compensation: $323.0K
Compensation as of Fiscal Year 2014.

Ekso Bionics Holdings, Inc. Key Developments

Ekso Bionics Holdings, Inc. Reports Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2014

Ekso Bionics Holdings, Inc. reported consolidated earnings results for the fourth quarter and year ended December 31, 2014. For the quarter, the company reported loss from operations of $4.859 million against $2.756 million a year ago. Total revenue was $1.5 million compared to $0.8 million during the same period of 2013. Net loss was $20.2 million, or $0.23 per basic and diluted share compared to a net loss of $2.8 million, or $0.13 per basic and diluted share for the same period of 2013. For the year, the company reported total revenue of $5.327 million against $3.302 million a year ago. Loss from operations was $16.794 million against $10.294 million a year ago. Net cash used in operating activities was $15.007 million against $9.063 million a year ago. Net loss was $33.8 million, or $0.43 per basic and diluted share compared to a net loss of $11.9 million, or $0.57 per basic and diluted share for the same period of 2013.

Ekso Bionics Holdings, Inc., Q4 2014 Earnings Call, Mar 17, 2015

Ekso Bionics Holdings, Inc., Q4 2014 Earnings Call, Mar 17, 2015

Ekso Bionics Holdings, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 05:00 PM

Ekso Bionics Holdings, Inc. Presents at 27th Annual ROTH Conference, Mar-10-2015 05:00 PM. Venue: The Ritz Carlton, 1 Ritz Carlton Dr, Dana Point, CA 92629, United States. Speakers: Max Scheder-Bieschin, Chief Financial Officer and Principal Accounting Officer.

Similar Private Companies By Industry

Company Name Region
Rapid Diagnostics United States
Carroll County Health Services Corporation United States
Health Associates, Inc. United States
Walco Holdings United States
Aetna Capital Trust II United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ekso Bionics Holdings, Inc., please visit www.eksobionics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.